CLINICAL TRIAL article
Front. Sports Act. Living
Sec. Exercise Physiology
Volume 7 - 2025 | doi: 10.3389/fspor.2025.1579221
This article is part of the Research TopicMechanistic Roles of Exercise on Cancer Progression, Recurrence and Survival OutcomesView all 3 articles
Effects of aerobic exercise on body composition and exerkines in colorectal cancer survivors
Provisionally accepted- 1Louisiana State University, Baton Rouge, United States
- 2Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Physical activity improves immune competency and is associated with a lower rate of cancer recurrence in colorectal cancer survivors. However, the exact mechanisms underlying these improvements remain unclear. Exercise-derived cytokines (exerkines), particularly IL-7 and IL-15, are crucial in maintaining optimal immune health. This study investigated whether a 12-week structured exercise training intervention increases IL-7 and IL-15 in colorectal cancer survivors. Sixty colorectal cancer survivors were randomized to a moderate-intensity home-based aerobic exercise group (150 min/week) or a control group for 12 weeks. IL-7 and IL-15 were quantified using ELISA, and body composition was measured using dual-energy X-ray absorptiometry. At baseline, participants treated with chemotherapy had lower IL-7 than those not treated with chemotherapy [−3.3 pg/mL (95% CI: −1.3, −5.4); p=0.002]. Baseline fitness capacity correlated with IL-15 (r=-0.37; p=0.004). IL-7 increased in the exercise group [2.3 pg/mL (95% CI: 0.9, 3.8; p=0.003)], but not in the control group [1.2 pg/mL (95% CI: 0.3, 2.8; p=0.31)]. IL-15 did not differ between groups. Longitudinal changes in IL-15 were associated with changes in body composition. Aerobic exercise may improve immune function in colorectal cancer survivors by restoring IL-7 after chemotherapy and improving IL-15 by altering body composition. This trial was registered at ClinicalTrials.gov (Identifier: NCT03975491; URL: https://clinicaltrials.gov/study/NCT03975491).
Keywords: IL-7 biomarker, IL-15, Exerkines, Clinical Trial, Exercise Intervention, Body Composition
Received: 24 Feb 2025; Accepted: 12 Jun 2025.
Copyright: © 2025 Cho, Chodzko, Compton, Yang, Heymsfield, Spielmann and Brown. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Justin Brown, Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.